|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.61 USD | -5.51% |
|
-29.43% | +1.53% |
| 07-31 | Novo Nordisk Shares Sink After Heart Disease Drug Candidate Fails Late-Stage Trial | MT |
| 07-31 | Wedbush Adjusts Monte Rosa Therapeutics Price Target to $27 From $37, Maintains Outperform Rating | MT |
| Market Cap | 1.4B 1.21B 1.13B 1.04B 1.96B 133B 1.99B 13.35B 5.23B 66.34B 5.24B 5.13B 219B | P/E 2026 * |
-9.98x | P/E 2027 * | -9x |
|---|---|---|---|---|---|
| Enterprise Value | 1.4B 1.21B 1.13B 1.04B 1.96B 133B 1.99B 13.35B 5.23B 66.34B 5.24B 5.13B 219B | EV / Sales 2026 * |
31.4x | EV / Sales 2027 * | 24x |
| Free-Float |
99.43% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -3.66% | ||
| 1 week | -29.43% | ||
| Current month | -3.63% | ||
| 1 month | -31.53% | ||
| 3 months | -18.65% | ||
| 6 months | -23.94% | ||
| Current year | +1.53% |
| 1 week | 14.87 |  | 22.72 |
| 1 month | 14.87 | | 25.16 |
| Current year | 13.69 | | 25.77 |
| 1 year | 4.12 | | 25.77 |
| 3 years | 2.44 | | 25.77 |
| 5 years | 2.44 | | 45.56 |
| 10 years | 2.44 | | 45.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Markus Warmuth
CEO | Chief Executive Officer | 55 | 31/12/2019 |
Magnus Walter
CTO | Chief Tech/Sci/R&D Officer | - | 16/03/2026 |
| Chief Operating Officer | 54 | 28/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Markus Warmuth
BRD | Director/Board Member | 55 | 31/12/2019 |
Ali Behbahani
BRD | Director/Board Member | 49 | 31/03/2020 |
| Director/Board Member | 57 | 31/05/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/07/26 | Sell | Chief Executive Officer | -9,500 | 0.0112% | ||
| 15/07/26 | Fiscal year | Chief Operating Officer | 13,053 | 0.0155% | ||
| 06/07/26 | Fiscal year | Chief Technology Officer | 18,000 | 0.0213% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.51% | -29.43% | +226.23% | +136.90% | 1.4B | |
| -0.36% | +0.14% | -0.95% | +14.33% | 48.53B | |
| -2.61% | -2.45% | +393.44% | +475.29% | 39.87B | |
| -0.91% | +8.86% | +27.01% | +7.31% | 38.68B | |
| -1.31% | -4.66% | +2.11% | +50.96% | 35.13B | |
| -2.41% | +2.59% | +11.68% | +41.16% | 29.79B | |
| +0.10% | -2.65% | +32.67% | +122.34% | 16.11B | |
| +0.63% | -4.11% | - | - | 16.08B | |
| -0.62% | +1.23% | +1.80% | +15.05% | 13.61B | |
| -2.64% | -7.17% | -4.93% | -37.59% | 12.62B | |
| Average | -1.58% | -1.98% | +76.56% | +91.75% | 25.18B | |
| Weighted average by Cap. | -1.28% | +1.66% | +75.98% | +105.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 44.48M 38.66M 36.09M 33.13M 62.47M 4.24B 63.56M 426M 167M 2.11B 167M 163M 6.97B | 58.17M 50.56M 47.2M 43.33M 81.7M 5.54B 83.13M 557M 218M 2.77B 219M 214M 9.12B |
| Net income | -167M -145M -136M -125M -235M -15.95B -239M -1.6B -627M -7.95B -628M -615M -26.23B | -194M -169M -157M -144M -272M -18.49B -277M -1.86B -727M -9.22B -728M -712M -30.41B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/08/26 | US$15.51 | -6.11% | 1,265,852 |
| 31/07/26 | US$16.52 | -27.16% | 7,467,901 |
| 30/07/26 | US$22.68 | +5.19% | 1,690,425 |
| 29/07/26 | US$21.56 | -2.18% | 1,233,805 |
| 28/07/26 | US$22.04 | -2.30% | 1,329,706 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLUE Stock
Select your edition
All financial news and data tailored to specific country editions
